A new treatment way of Herpes Zoster with Allokin-alpha

One of the new approved treatment of Herpes Virus infections is a national antiviral drug Allokin-alpha.
In comparison with acyclovir (AC) the tests showed the safety and clinical efficiency of Allokin-alpha in the treatment of patients with Herpes Zoster.

The following parameters were weighted in the analysis of the therapy results:

• hospitalization and disease duration;
• pain and rash duration;
• frequency of complications as an eye damage in ganglioneuritis of the 1-st branch of trigeminal nerve.

The parenteral use of Allokin-alpha did not cause any allergic or other adverse reactions, it was well accepted and convenient in use, it can be combined with other drugs.

When Allokin-Alpha was included in the treatment of patients with Herpes Zoster, Ophthalmic Herpes did not have a progress at all (if it had not developed before the treatment with Allokin-alpha), and 30% of the patients had a regression of eye incipient lesion.

HZ with eye lesion follows in the course of lymphopenia (secondary immune deficiency), but after a combined therapy (AC + Allokin-alpha) the number of lymphocytes increased by 50%, thus the immuno-biological resistance of the body had been increasing.

The researches results of F. I. Ershov and others (2003) in the treatment with Allokin-alpha in patients with Genital Herpes have identified the increase of cytokines production, favoring the formation of TX1-immune response mostly, which is very important in rehabilitation of the body from Herpes Viruses (F. I. Ershov et al., 2003; V. A. Isakov. and others, 2006).

Allokin-alpha had induced the synthesis of anti-inflammatory cytokine IL-10 that is the answer for the anti-inflammatory and analgesic effect of the drug in the treatment of patients with HZ. These influence results of Allokin-alpha on the interferon status, cytokine profile and the expression of cytokine genes allow to explain the high clinical efficiency of Herpes Zoster treatment with Allokin-alpha.

The influence of treatment with Allokine-alpha in patients with Herpes Zoster on
the duration of main clinical symptoms
 

Note: * - p < 0,05

Including Allokin-alpha into a complex HZ therapy, has contributed to a significant reduction in the duration of pain and burning sensation by 1/3. It allowed to avoid any complication of HZ in the form of eye lesions and the clinical symptoms of already developed Ophthalmic Herpes had passed quickly.

Allokin-alpha can be recommended for the wide practical application as a drug of choice in the complex therapy of Herpes Zoster..

Ask your gynecologist if he (she) has an experience in treatment of human papillomavirus infection to the complete removal of human papilloma virus from the body?